Company

News

The common goal is the advancement of women’s health and welfare, through tackling the most burdensome crisis facing the female population, such as cervical cancer.

NTL Healthcare, Strategic Business Partnership with Cardinal Health Korea

Author
admin
Date
2021-06-03 02:22
Views
21
NTL Healthcare Co., Ltd. announced on the 31st that it had signed a strategic business partnership agreement with Cardinal Health Korea Co., Ltd. to strengthen its obstetrics and gynecology business.



NTL Healthcare (CEO Taehee Kim), a company specializing in obstetrics and gynecology, signed a business agreement with Cardinal Health Korea (CEO Scott Brian Zimmerman) to expand sales of SCD Sleeve.

On the 28th, at the signing ceremony of the business agreement held at Cardinal Health Korea headquarters in Joong-gu, Seoul, NTL Healthcare CEO Kim Tae-hee, Cardinal Health Korea CEO Cho Seung-je, and Han Jong-su director attended.

The SCD Sleeve (limb compression circulatory device) is a therapeutic material that prevents the death of patients due to pulmonary artery pulmonary embolism (PE) by preventing lower extremity edema, varicose veins, and deep vein thrombosis (DVT) occurring before and after childbirth. It is characterized by checking blood flow and providing sequential compression for each part with a customized pressure for each patient.



Through this agreement, both companies will conduct joint marketing to strengthen their sales of obstetrics and gynecology and focus on selling the SCD Sleeve.

Kim Tae-hee, CEO of NTL Healthcare, said "We are happy to supply the world's best products through an agreement with Cardinal Health, a global medical device distributor. As interest in deep vein thrombosis (DVT) has increased, we expect to contribute to the improvement of maternal health and a healthy life through cooperation with Cardinal Health."

Meanwhile, NTL Healthcare is the first company to introduce ‘Telecervico(cervical magnification screening system)’ in Korea in 1996, and recently developed 'CerviCare AI', an artificial intelligence (AI) imaging screening system that learned about 6 million cases of cervical cancer image big data. In addition to cervical cancer, NTL also provides a variety of screening services, including women's cancer screening, and plans to continue to develop and supply new products that can improve women's diseases.